NCI News Releases
27 February 2020
The latest cancer news from the U.S. government's principal agency for cancer research.-
Immunotherapy drug improves outcomes for some children with relapsed leukemia
For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children’s Oncology Group trial shows.
-
Study quantifies impact of NCI-sponsored trials on clinical cancer care
Nearly half of phase 3 cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals, a study in JAMA Network Open shows.
-
NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism
Findings from a new NCI study of patients who received radioactive iodine (RAI) treatment for hyperthyroidism show an association between the dose of treatment and long-term risk of death from solid cancers, including breast cancer.
NCI Fact Sheets
27 February 2020
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Tumor Markers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.
-
Targeted Cancer Therapies
A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.
-
Genetic Testing for Inherited Cancer Susceptibility Syndromes
A fact sheet about genetic testing for inherited cancer risk, including who should consider testing, how to understand test results, and who has access to a person’s test results. Also contains information about at-home, or direct-to-consumer, genetic tests.
